JULIE WISCHER: Open Payments
NPI 1720538085 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 13 payments from 8 companies in 2025. Trend: 2023 $240 · 2024 $48 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $244 |
| CVRx, Inc. | 1 | $189 |
| BridgeBio Pharma, Inc. | 3 | $99 |
| Alnylam Pharmaceuticals Inc. | 2 | $65 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Novo Nordisk Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: Adempas, Barostim Neo System, Attruby, AMVUTTRA, Wegovy, JARDIANCE, VYNDAQEL, FARXIGA.
Industry payments across OH — which companies pay providers there.
